PIRTOBRUTINIB

Clinical trials for PIRTOBRUTINIB explained in plain language.

Never miss a new study

Get alerted when new PIRTOBRUTINIB trials appear

Sign up with your email to follow new studies for PIRTOBRUTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug cocktail aims to fight tough brain cancers in frail patients

Disease control Recruiting now

This study is testing whether a combination of three drugs—thiotepa, pirtobrutinib, and sintilimab—can help control a type of lymphoma that affects the brain or has returned after previous treatment. It is for adults who are frail or whose cancer has not responded to standard the…

Matched conditions: PIRTOBRUTINIB

Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

PIRTOBRUTINIB

Get alerted when new PIRTOBRUTINIB trials appear

New drug cocktail aims to fight tough brain cancers in frail patients